Qi Li
Direttore/Membro del Consiglio presso Beijing Mabworks Biotech Co., Ltd.
Profilo
Qi Li is currently a Member-Supervisory Board at Beijing Mabworks Biotech Co., Ltd.
Mr. Li completed an undergraduate degree from Capital Normal University in 2012 and another undergraduate degree from Capital University of Economics & Business in 2008.
Posizioni attive di Qi Li
Società | Posizione | Inizio |
---|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 20/03/2021 |
Formazione di Qi Li
Capital Normal University | Undergraduate Degree |
Capital University of Economics & Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Qi Li